clinical

Articles

A window into the world of academic retina practice today.

Practice perspective: Academic retina 

Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of 

Study demonstrates results of pegcetacoplan as a geographic atrophy therapy.

Addressing the urgent, unmet need among patients with geographic atrophy

Genetic and clinical research reveals new type of macular dystrophy, a cause of central vision loss.

New genetic eye disease discovered by NIH researchers

Modern Retina™ Case-Based Roundtables create an environment for ophthalmology’s brightest minds to examine complex, real-world patient cases in a discussion-based setting. Led by an expert in the topic, the group dissects the case together to improve their knowledge of rare diseases and niche diagnoses.

In Fort Lauderdale, Florida, Modern Retina™ hosted Uveitis Case-Based Roundtables. Moderators Thomas Albini, MD, and Eduardo Uchiyama, MD, are uveitis specialists who have encountered intriguing cases in the clinic. Attendees asked questions and reviewed imaging of the cases in hopes of improving their overall patient care.

Roundtable 1, led by Dr. Albini and discussed here, investigates two intriguing cases.

Pearls for recognizing and treating uveitis

Although off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.

Perspectives on intravenous bevacizumab repackaged for intravitreal use

By co-culturing the differentiated microglia with retinal organoids, investigators found they may be able to recapitulate retinal development.

Functional microglia derived from human pluripotent stem cells in retinal organoids

After 10 years, AREDS2 formula shows increased efficacy compared to original formula, benefit of eliminating beta-carotene.

Dietary supplements beneficial for slowing AMD, confirmed by NIH

With clearer imaging and enhanced resolution, the new OCT approach could improve medical diagnostic imaging.

New approach to OCT image biomedical samples at higher contrast, resolution

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Videos

Though the speed of traditional guillotine cutters has increased significantly in recent years, there are certain limitations. With the advent of hypersonic vitrectomy, Sunir J. Garg, MD, FACS, explains how retinal surgeons can remove the vitreous gel with more efficiency.

Hypersonic vitrectomy: Novel technology for vitreous removal

While the DAZZLE trial failed to meet its primary endpoint, KSI-301 demonstrated good initial visual gains and anatomic effects as well as positive durability.